The Burden of Living With Cutaneous Lupus Erythematosus.
cutaneous lupus erythematosus (CLE)
disease burden
psychosocial impact
quality of life
racial minorities
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2022
2022
Historique:
received:
16
03
2022
accepted:
24
05
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
Cutaneous lupus erythematosus (CLE) is a group of heterogeneous autoimmune disorders primarily affecting the skin. Patients with these conditions are mostly young women when they become sick and often suffer from recurrent skin symptoms or longstanding changes in their physical appearance. CLE disorders lead to different levels of morbidity and can impact profoundly patients' quality of life, particularly in the psychological and social health domains. This review provides a summary of recent research investigating the psychosocial burden of living with CLE and the intersect amongst the disease characteristics, patient factors, and social determinants of health. Furthermore, this review provides insight into patient care and research needs that remain unmet to improve the quality of life of patients living with CLE.
Identifiants
pubmed: 36017007
doi: 10.3389/fmed.2022.897987
pmc: PMC9395260
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
897987Informations de copyright
Copyright © 2022 Drenkard, Barbour, Greenlund and Lim.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Brain Res. 2000 Dec 15;886(1-2):172-189
pubmed: 11119695
Arthritis Care Res (Hoboken). 2016 Nov;68(11):1664-1670
pubmed: 27015109
Ethn Dis. 2007 Winter;17(1):40-8
pubmed: 17274208
Lupus. 2000;9(6):417-23
pubmed: 10981645
J Psychosom Res. 2001 Jan;50(1):11-5
pubmed: 11259795
Arch Intern Med. 1993 Sep 27;153(18):2093-101
pubmed: 8379800
J Am Acad Dermatol. 2013 Jul;69(1):19-24
pubmed: 23541758
J Am Acad Dermatol. 2016 Feb;74(2):377-9
pubmed: 26775780
Am J Clin Dermatol. 2019 Jun;20(3):465-475
pubmed: 30877492
Lupus. 2020 Nov;29(13):1691-1703
pubmed: 32883161
Autoimmun Rev. 2005 Jun;4(5):296-302
pubmed: 15990077
Lupus. 2017 Jan;26(1):48-53
pubmed: 27235406
J Am Acad Dermatol. 1981 Apr;4(4):471-5
pubmed: 7229150
Clin Exp Dermatol. 2020 Jan;45(1):89-91
pubmed: 31120600
Arthritis Care Res (Hoboken). 2015 May;67(6):817-28
pubmed: 25369985
Int J Womens Dermatol. 2018 Apr 13;4(3):152-158
pubmed: 30175217
Lupus Sci Med. 2021 Aug;8(1):
pubmed: 34452954
Postepy Dermatol Alergol. 2017 Feb;34(1):36-41
pubmed: 28261029
Lupus. 2010 Aug;19(9):1050-70
pubmed: 20693199
Autoimmun Rev. 2005 Jun;4(5):253-63
pubmed: 15990071
J Psychosom Res. 2017 Mar;94:32-38
pubmed: 28183400
Lupus Sci Med. 2021 Nov;8(1):
pubmed: 34853149
Front Med (Lausanne). 2018 Jan 29;4:262
pubmed: 29435447
Arch Dermatol. 2008 Aug;144(8):1061-2
pubmed: 18711088
Lupus. 2017 Jan;26(1):73-83
pubmed: 27230554
Br J Dermatol. 2016 May;174(5):1051-60
pubmed: 26748551
J Intern Med. 2007 Mar;261(3):245-54
pubmed: 17305647
Br J Dermatol. 2012 Jan;166(1):29-35
pubmed: 21910708
Ethn Dis. 1992 Summer;2(3):207-21
pubmed: 1467758
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4770-5
pubmed: 11287659
Psychosom Med. 2012 May;74(4):432-9
pubmed: 22582340
Am Psychol. 2020 Dec;75(9):1300-1311
pubmed: 33382299
Psychosom Med. 1996 Sep-Oct;58(5):459-71
pubmed: 8902897
Lupus Sci Med. 2016 Apr 12;3(1):e000143
pubmed: 27099765
Br J Dermatol. 2011 Jun;164(6):1335-41
pubmed: 21574972
Br J Dermatol. 2018 Nov;179(5):1095-1101
pubmed: 29885269
Br J Dermatol. 2017 Oct;177(4):e147-e149
pubmed: 28338221
J Drugs Dermatol. 2011 Dec;10(12):1413-20
pubmed: 22134565
J Invest Dermatol. 1996 Nov;107(5):707-13
pubmed: 8875954
Arthritis Rheum. 1999 Jan;42(1):51-60
pubmed: 9920014
Lupus. 2018 Jun;27(7):1107-1115
pubmed: 29514557
Arthritis Care Res (Hoboken). 2019 Jan;71(1):95-103
pubmed: 29669194
Br J Dermatol. 2014 Feb;170(2):315-21
pubmed: 24111880
J Am Coll Cardiol. 2005 Mar 1;45(5):637-51
pubmed: 15734605
Br J Dermatol. 2013 Jan;168(1):145-53
pubmed: 22708924
J Am Acad Dermatol. 2015 Apr;72(4):628-33
pubmed: 25648823
Best Pract Res Clin Rheumatol. 2013 Jun;27(3):391-404
pubmed: 24238695
BMC Med. 2019 Feb 15;17(1):31
pubmed: 30764826
Lupus. 2017 Nov;26(13):1435-1439
pubmed: 28618892
Lupus Sci Med. 2019 Oct 30;6(1):e000344
pubmed: 31798917
J Am Acad Dermatol. 2020 Aug;83(2):343-363
pubmed: 32360722
Lancet. 2008 Nov 8;372(9650):1661-9
pubmed: 18994664
Arch Dermatol. 2009 Mar;145(3):249-53
pubmed: 19289752
J Am Acad Dermatol. 2011 May;64(5):849-58
pubmed: 21397983
N Engl J Med. 1998 Jan 15;338(3):171-9
pubmed: 9428819
Am J Epidemiol. 1997 Mar 1;145(5):408-15
pubmed: 9048514
Lupus. 2014;23(1):93-101
pubmed: 24197553
Lupus. 2012 Nov;21(13):1467-71
pubmed: 22930206
Ann Rheum Dis. 2021 Sep;80(9):1190-1200
pubmed: 34083207
JAMA Dermatol. 2014 Mar;150(3):291-6
pubmed: 24477339
J Psychosom Res. 2002 Jan;52(1):1-23
pubmed: 11801260
Br J Dermatol. 2015 Sep;173(3):824-6
pubmed: 25639859
Expert Rev Clin Immunol. 2020 Aug;16(8):829-837
pubmed: 32746644